nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.127	0.197	CbGbCtD
Anagrelide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.119	0.185	CbGbCtD
Anagrelide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.119	0.185	CbGbCtD
Anagrelide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.108	0.167	CbGbCtD
Anagrelide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0903	0.14	CbGbCtD
Anagrelide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0817	0.127	CbGbCtD
Anagrelide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.000663	CcSEcCtD
Anagrelide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000235	0.000662	CcSEcCtD
Anagrelide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000235	0.000661	CcSEcCtD
Anagrelide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000234	0.000661	CcSEcCtD
Anagrelide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00066	CcSEcCtD
Anagrelide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000659	CcSEcCtD
Anagrelide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000659	CcSEcCtD
Anagrelide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000659	CcSEcCtD
Anagrelide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000659	CcSEcCtD
Anagrelide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000233	0.000657	CcSEcCtD
Anagrelide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000657	CcSEcCtD
Anagrelide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000655	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000654	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000652	CcSEcCtD
Anagrelide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000231	0.000651	CcSEcCtD
Anagrelide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000651	CcSEcCtD
Anagrelide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.000651	CcSEcCtD
Anagrelide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000651	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.00065	CcSEcCtD
Anagrelide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00065	CcSEcCtD
Anagrelide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000646	CcSEcCtD
Anagrelide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000646	CcSEcCtD
Anagrelide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.000646	CcSEcCtD
Anagrelide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.000645	CcSEcCtD
Anagrelide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000645	CcSEcCtD
Anagrelide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000644	CcSEcCtD
Anagrelide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000643	CcSEcCtD
Anagrelide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000642	CcSEcCtD
Anagrelide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000642	CcSEcCtD
Anagrelide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000228	0.000641	CcSEcCtD
Anagrelide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000641	CcSEcCtD
Anagrelide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000641	CcSEcCtD
Anagrelide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000227	0.000639	CcSEcCtD
Anagrelide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000227	0.000639	CcSEcCtD
Anagrelide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000638	CcSEcCtD
Anagrelide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000637	CcSEcCtD
Anagrelide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000637	CcSEcCtD
Anagrelide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.000636	CcSEcCtD
Anagrelide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.000635	CcSEcCtD
Anagrelide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000634	CcSEcCtD
Anagrelide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000634	CcSEcCtD
Anagrelide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000634	CcSEcCtD
Anagrelide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000632	CcSEcCtD
Anagrelide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000224	0.00063	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00063	CcSEcCtD
Anagrelide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.000628	CcSEcCtD
Anagrelide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000626	CcSEcCtD
Anagrelide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000624	CcSEcCtD
Anagrelide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000221	0.000623	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000622	CcSEcCtD
Anagrelide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000621	CcSEcCtD
Anagrelide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00062	CcSEcCtD
Anagrelide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00062	CcSEcCtD
Anagrelide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00062	CcSEcCtD
Anagrelide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.00062	CcSEcCtD
Anagrelide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000619	CcSEcCtD
Anagrelide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000618	CcSEcCtD
Anagrelide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000219	0.000618	CcSEcCtD
Anagrelide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000618	CcSEcCtD
Anagrelide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.000618	CcSEcCtD
Anagrelide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000616	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000616	CcSEcCtD
Anagrelide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000616	CcSEcCtD
Anagrelide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.000615	CcSEcCtD
Anagrelide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000615	CcSEcCtD
Anagrelide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000613	CcSEcCtD
Anagrelide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000613	CcSEcCtD
Anagrelide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000613	CcSEcCtD
Anagrelide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000611	CcSEcCtD
Anagrelide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00061	CcSEcCtD
Anagrelide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00061	CcSEcCtD
Anagrelide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.00061	CcSEcCtD
Anagrelide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000216	0.00061	CcSEcCtD
Anagrelide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.000609	CcSEcCtD
Anagrelide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000216	0.000609	CcSEcCtD
Anagrelide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000608	CcSEcCtD
Anagrelide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000607	CcSEcCtD
Anagrelide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000606	CcSEcCtD
Anagrelide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000605	CcSEcCtD
Anagrelide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000605	CcSEcCtD
Anagrelide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000605	CcSEcCtD
Anagrelide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000604	CcSEcCtD
Anagrelide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000602	CcSEcCtD
Anagrelide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000601	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000601	CcSEcCtD
Anagrelide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000213	0.0006	CcSEcCtD
Anagrelide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000598	CcSEcCtD
Anagrelide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000598	CcSEcCtD
Anagrelide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000597	CcSEcCtD
Anagrelide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000597	CcSEcCtD
Anagrelide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000596	CcSEcCtD
Anagrelide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.000596	CcSEcCtD
Anagrelide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000595	CcSEcCtD
Anagrelide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000211	0.000594	CcSEcCtD
Anagrelide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000594	CcSEcCtD
Anagrelide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000592	CcSEcCtD
Anagrelide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.000591	CcSEcCtD
Anagrelide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.000591	CcSEcCtD
Anagrelide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00059	CcSEcCtD
Anagrelide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00059	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00059	CcSEcCtD
Anagrelide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000209	0.000589	CcSEcCtD
Anagrelide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000589	CcSEcCtD
Anagrelide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000209	0.000589	CcSEcCtD
Anagrelide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000588	CcSEcCtD
Anagrelide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000588	CcSEcCtD
Anagrelide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.000587	CcSEcCtD
Anagrelide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000585	CcSEcCtD
Anagrelide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000208	0.000585	CcSEcCtD
Anagrelide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000585	CcSEcCtD
Anagrelide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000584	CcSEcCtD
Anagrelide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000584	CcSEcCtD
Anagrelide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000584	CcSEcCtD
Anagrelide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.000583	CcSEcCtD
Anagrelide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000206	0.000581	CcSEcCtD
Anagrelide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000206	0.00058	CcSEcCtD
Anagrelide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00058	CcSEcCtD
Anagrelide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000579	CcSEcCtD
Anagrelide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000577	CcSEcCtD
Anagrelide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000576	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000575	CcSEcCtD
Anagrelide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000575	CcSEcCtD
Anagrelide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.000575	CcSEcCtD
Anagrelide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000571	CcSEcCtD
Anagrelide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00057	CcSEcCtD
Anagrelide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000569	CcSEcCtD
Anagrelide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000568	CcSEcCtD
Anagrelide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000568	CcSEcCtD
Anagrelide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000567	CcSEcCtD
Anagrelide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000567	CcSEcCtD
Anagrelide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000564	CcSEcCtD
Anagrelide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000564	CcSEcCtD
Anagrelide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000563	CcSEcCtD
Anagrelide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000563	CcSEcCtD
Anagrelide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000563	CcSEcCtD
Anagrelide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000561	CcSEcCtD
Anagrelide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000561	CcSEcCtD
Anagrelide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000558	CcSEcCtD
Anagrelide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.000557	CcSEcCtD
Anagrelide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000556	CcSEcCtD
Anagrelide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000197	0.000556	CcSEcCtD
Anagrelide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000555	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000554	CcSEcCtD
Anagrelide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000553	CcSEcCtD
Anagrelide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00055	CcSEcCtD
Anagrelide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000549	CcSEcCtD
Anagrelide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000547	CcSEcCtD
Anagrelide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000546	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000545	CcSEcCtD
Anagrelide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000544	CcSEcCtD
Anagrelide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000543	CcSEcCtD
Anagrelide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000542	CcSEcCtD
Anagrelide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000542	CcSEcCtD
Anagrelide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000542	CcSEcCtD
Anagrelide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00054	CcSEcCtD
Anagrelide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00054	CcSEcCtD
Anagrelide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00054	CcSEcCtD
Anagrelide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00054	CcSEcCtD
Anagrelide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00054	CcSEcCtD
Anagrelide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000537	CcSEcCtD
Anagrelide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000535	CcSEcCtD
Anagrelide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000534	CcSEcCtD
Anagrelide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000528	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000528	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000525	CcSEcCtD
Anagrelide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000524	CcSEcCtD
Anagrelide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000524	CcSEcCtD
Anagrelide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000521	CcSEcCtD
Anagrelide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00052	CcSEcCtD
Anagrelide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00052	CcSEcCtD
Anagrelide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00052	CcSEcCtD
Anagrelide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000517	CcSEcCtD
Anagrelide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000183	0.000517	CcSEcCtD
Anagrelide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000516	CcSEcCtD
Anagrelide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000516	CcSEcCtD
Anagrelide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000516	CcSEcCtD
Anagrelide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000512	CcSEcCtD
Anagrelide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000512	CcSEcCtD
Anagrelide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000512	CcSEcCtD
Anagrelide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00051	CcSEcCtD
Anagrelide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000509	CcSEcCtD
Anagrelide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000505	CcSEcCtD
Anagrelide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000504	CcSEcCtD
Anagrelide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000502	CcSEcCtD
Anagrelide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000501	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000501	CcSEcCtD
Anagrelide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.0005	CcSEcCtD
Anagrelide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000177	0.0005	CcSEcCtD
Anagrelide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000499	CcSEcCtD
Anagrelide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000499	CcSEcCtD
Anagrelide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000497	CcSEcCtD
Anagrelide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000496	CcSEcCtD
Anagrelide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000496	CcSEcCtD
Anagrelide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00049	CcSEcCtD
Anagrelide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000488	CcSEcCtD
Anagrelide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000483	CcSEcCtD
Anagrelide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000483	CcSEcCtD
Anagrelide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000482	CcSEcCtD
Anagrelide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000481	CcSEcCtD
Anagrelide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000481	CcSEcCtD
Anagrelide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00048	CcSEcCtD
Anagrelide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000478	CcSEcCtD
Anagrelide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000476	CcSEcCtD
Anagrelide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000476	CcSEcCtD
Anagrelide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000474	CcSEcCtD
Anagrelide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000473	CcSEcCtD
Anagrelide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000472	CcSEcCtD
Anagrelide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000467	CcSEcCtD
Anagrelide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000461	CcSEcCtD
Anagrelide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000458	CcSEcCtD
Anagrelide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000458	CcSEcCtD
Anagrelide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000454	CcSEcCtD
Anagrelide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000453	CcSEcCtD
Anagrelide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000452	CcSEcCtD
Anagrelide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.00045	CcSEcCtD
Anagrelide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.00045	CcSEcCtD
Anagrelide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000449	CcSEcCtD
Anagrelide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000447	CcSEcCtD
Anagrelide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000447	CcSEcCtD
Anagrelide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000436	CcSEcCtD
Anagrelide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000434	CcSEcCtD
Anagrelide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000432	CcSEcCtD
Anagrelide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000431	CcSEcCtD
Anagrelide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00043	CcSEcCtD
Anagrelide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00043	CcSEcCtD
Anagrelide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000428	CcSEcCtD
Anagrelide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000424	CcSEcCtD
Anagrelide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000418	CcSEcCtD
Anagrelide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000416	CcSEcCtD
Anagrelide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000416	CcSEcCtD
Anagrelide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00041	CcSEcCtD
Anagrelide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000406	CcSEcCtD
Anagrelide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000402	CcSEcCtD
Anagrelide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000402	CcSEcCtD
Anagrelide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000398	CcSEcCtD
Anagrelide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000398	CcSEcCtD
Anagrelide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000397	CcSEcCtD
Anagrelide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000396	CcSEcCtD
Anagrelide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000386	CcSEcCtD
Anagrelide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000383	CcSEcCtD
Anagrelide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000383	CcSEcCtD
Anagrelide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000383	CcSEcCtD
Anagrelide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000381	CcSEcCtD
Anagrelide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000375	CcSEcCtD
Anagrelide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000369	CcSEcCtD
Anagrelide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000366	CcSEcCtD
Anagrelide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000365	CcSEcCtD
Anagrelide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000363	CcSEcCtD
Anagrelide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000361	CcSEcCtD
Anagrelide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000344	CcSEcCtD
Anagrelide—PDE3A—blood plasma—acquired immunodeficiency syndrome	7.89e-05	0.328	CbGeAlD
Anagrelide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	3.49e-05	0.145	CbGeAlD
Anagrelide—PDE3A—blood—acquired immunodeficiency syndrome	2.89e-05	0.12	CbGeAlD
Anagrelide—PDE3A—lung—acquired immunodeficiency syndrome	2.53e-05	0.105	CbGeAlD
Anagrelide—PDE3A—brain—acquired immunodeficiency syndrome	1.79e-05	0.0745	CbGeAlD
Anagrelide—PDE3A—lymph node—acquired immunodeficiency syndrome	1.73e-05	0.0719	CbGeAlD
Anagrelide—CYP1A2—digestive system—acquired immunodeficiency syndrome	1.34e-05	0.0558	CbGeAlD
Anagrelide—CYP1A2—blood—acquired immunodeficiency syndrome	1.28e-05	0.0531	CbGeAlD
Anagrelide—CYP1A2—lung—acquired immunodeficiency syndrome	1.12e-05	0.0466	CbGeAlD
